Mukka Proteins Ltd
Mukka Proteins Ltd Q4 FY26 Results & Presentation Highlights: Revenue ₹381.6 Cr, PAT ₹21.4 Cr
Q4 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Mukka Proteins Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q4 FY26 Revenue from Operations: ₹381.6 Cr - Q4 FY25 Revenue from Operations: ₹380.6 Cr - Year-on-Year (Q4) Revenue Growth: Slight increase of ₹1 Cr (~0.26%) from Q4 FY25 to Q4 FY26 - FY26 Revenue from Operations: ₹1,449.5 Cr - FY25 Revenue from Operations: ₹1,006.4 Cr - Year-on-Year (FY) Revenue Growth: ₹443.1 Cr (approx. Q4 FY26 Revenue from operations: ₹381.6 Cr (up from ₹380.6 Cr in Q4 FY25) - Q4 FY26 EBITDA: ₹49.2 Cr, Margin: 12.9% (up from ₹33.2 Cr and 8.7% in Q4 FY25) — significant YoY improvement - Q4 FY26 P
From Mukka Proteins Ltd's Q4 FY26 earnings-call transcript · updated 25 Sept 2026.
Revenue & Sales Performance
- Q4 FY26 Revenue from Operations: ₹381.6 Cr
- Q4 FY25 Revenue from Operations: ₹380.6 Cr
- Year-on-Year (Q4) Revenue Growth: Slight increase of ₹1 Cr (~0.26%) from Q4 FY25 to Q4 FY26
- FY26 Revenue from Operations: ₹1,449.5 Cr
- FY25 Revenue from Operations: ₹1,006.4 Cr
- Year-on-Year (FY) Revenue Growth: ₹443.1 Cr (approx. 44%) increase from FY25 to FY26
- Explicit Revenue Outlook:
- Targeted revenue more than doubles by FY30: from ₹1,449 Cr (FY26) to over ₹3,000 Cr by FY30 (Page 11)
2 more points management made on revenue & sales performance
Profitability & Margins
See what Mukka Proteins Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Bengaluru Leachate Treatment Project
- CAPEX: ~₹100 Cr
- Order Value: ₹474.89 Cr (ex-GST)
- JV Stake: 76%
- Timeline: ~6 months construction; 4-year project
- Client: Bengaluru Solid Waste Management Ltd (BSWML)
- Oman Facility Expansion
- Location: Aljoubah Industrial Area, Oman
- Plant Size: 21,249 sq. mt
- Status: Underway; operations expected to commence in coming quarters
2 more points management made on capital expenditure plans
Top-ranked in Food Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Mukka Proteins Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Mukka Proteins Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹381 Cr, net profit ₹21 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Mukka Proteins Ltd's management said in earlier quarters
Others in Food Products this season
- Shri Ahimsa Naturals Ltd (Q4 FY26)
Revenue figures (₹ in Crs) for FY: . Key investor presentation takeaways from Shri Ahimsa Naturals Ltd's Q4 FY26 investor presentation — and how it ranks agains
- Prataap Snacks (Q4 FY26)
Q4 FY26 revenue from operations was ₹418.1 crore (₹4,180.6 Mn), up 4.9% YoY from ₹398.5 crore (₹3,985.2 Mn) in Q4 FY25. Key investor presentation takeaways from
- Proventus Agro. (Q4 FY26)
Reported revenue for FY26: ₹659 Cr, a ~58% increase YoY vs FY25 (Page 26, 14). Key investor presentation takeaways from Proventus Agrocom Ltd's Q4 FY26 investor
- Pajson Agro India Ltd (Q4 FY26)
Revenue growth is supported by strong repeat orders (78% from existing customers) and increased distribution. Key concall takeaways from Pajson Agro India…
Frequently Asked Questions
What were Mukka Proteins Ltd Q4 FY26 results?
Q4 FY26 Revenue from Operations: ₹381.6 Cr - Q4 FY25 Revenue from Operations: ₹380.6 Cr - Year-on-Year (Q4) Revenue Growth: Slight increase of ₹1 Cr (~0.26%) from Q4 FY25 to Q4 FY26 - FY26 Revenue from Operations: ₹1,449.5 Cr - FY25 Revenue from Operations: ₹1,006.4 Cr - Year-on-Year (FY) Revenue Growth: ₹443.1 Cr (approx. Q4 FY26 Revenue from operations: ₹381.6 Cr (up from ₹380.6 Cr in Q4 FY25) - Q4 FY26 EBITDA: ₹49.2 Cr, Margin: 12.9% (up from ₹33.2 Cr and 8.7% in Q4 FY25) — significant YoY improvement - Q4 FY26 P
What is Mukka Proteins Ltd share price analysis?
Mukka Proteins Ltd currently shows a neutral. The stock trades at a P/E of 11.7 with a market cap of ₹808 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mukka Proteins Ltd planning capital expenditure?
Bengaluru Leachate Treatment Project - CAPEX: ~₹100 Cr - Order Value: ₹474.89 Cr (ex-GST) - JV Stake: 76% - Timeline: ~6 months construction; 4-year project - Client: Bengaluru Solid Waste Management Ltd (BSWML) - Oman Facility Expansion - Location: Aljoubah Industrial Area, Oman - Plant Size: 21,249 sq.
Keep Mukka Proteins Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.